Sage Therapeutics Inc (SAGE) is Trading Lower on Unusual Volume for January 07

Equities Staff  |

Sage Therapeutics Inc (SAGE) experienced unusually high volume on Jan. 07, as the stock lost 5.79% to a closing price of $46.49. The stock saw 2.35 million shares trade hands over the course of the day on 17,199 trades. Given that the stock’s average daily volume over the last month has been 392,420 shares a day, this represents a pretty substantial spike over the norm.

Sage Therapeutics Inc has a P/B ratio of 6.78. The stock has traded between $89.04 and $35.00 over the last 52-weeks, its 50-day SMA is now $51.53, and its 200-day SMA $58.10.

Sage Therapeutics Inc is a biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare central nervous system disorders, where there are inadequate or no approved existing therapies.

Headquartered in Cambridge, MA, Sage Therapeutics Inc has 31 employees and is currently under the leadership of CEO Jeffrey M. Jonas.

For a complete fundamental analysis analysis of Sage Therapeutics Inc, check out’s Stock Valuation Analysis report for SAGE. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Radient Technologies Inc.

Radient Technologies Inc is engaged in research, development and commercialization of environmentally responsible technology for the extraction, isolation and purification of soluble products from a wide range of materials using…